APOE and Alzheimer disease: While this in part reflects differences in cohort design (e.g., target age range; enrichment for family history of AD dementia), we cannot rule out the possibility of survival effects in the oldest participants, given APOE-ε4 and AD-PRS effects and frequencies may vary with age (e.g., [8, 73–75]).